No Data
Express News | Piper Sandler Expands Healthcare Investment Banking Team With the Addition of John Kerins
Piper Sandler Cut to Neutral From Buy by Goldman Sachs
Piper Sandler Price Target Announced at $317.00/Share by Goldman Sachs
Piper Sandler Analyst Ratings
Goldman Sachs Downgrades Piper Sandler(PIPR.US) to Hold Rating, Cuts Target Price to $317
Piper Sandler Adds Paul Leece, Jeremi Martin and Daniel Allmomen to Its Energy, Power & Infrastructure Investment Banking Group >PIPR